.55
  Price1.85%   +0.0100
(After Hours: .57 +0.0190 +3.45%)
Aug-10-22 07:05AM Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022GlobeNewswire Inc.
Aug-08-22 03:05AM Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From FridayBenzinga
Aug-05-22 03:06AM Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike HigherBenzinga
12:53PM Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day SessionBenzinga
Aug-05-22 12:02PM Dow Drops 150 Points, Crude Oil Rises Over 2%Benzinga
08:38AM Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public OfferingGlobeNewswire Inc.
Aug-05-22 07:35AM Why Is Marker Therapeutics Trading Higher By 119%: Here Are 42 Stocks Moving PremarketBenzinga
06:12AM Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From YesterdayBenzinga
Aug-04-22 01:12AM Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day SessionBenzinga
06:51AM Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving PremarketBenzinga
Aug-04-22 05:54AM This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From YesterdayBenzinga
Aug-03-22 12:59PM Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday's Mid-Day SessionBenzinga
07:50AM This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving PremarketBenzinga
Jun-06-22 07:05AM Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual MeetingGlobeNewswire Inc.
Jun-01-22 07:05AM Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®GlobeNewswire Inc.
May-31-22 08:36AM Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual ConferenceGlobeNewswire Inc.
May-24-22 04:05AM Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)GlobeNewswire Inc.
May-17-22 07:30AM Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience ProgramGlobeNewswire Inc.
May-12-22 06:50AM Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®GlobeNewswire Inc.
May-03-22 07:05AM Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022GlobeNewswire Inc.
Apr-27-22 07:05AM Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®GlobeNewswire Inc.
Apr-26-22 07:05AM Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking AbilityGlobeNewswire Inc.
Mar-14-22 04:05AM Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswire Inc.
Feb-17-22 05:20AM Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire Inc.
Helius Medical Technologies, Inc., a medical technology company, focuses on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company develops, licenses, or acquires noninvasive platform technologies that amplify the brain's ability to heal itself. It is developing portable neuromodulation stimulator or PoNS, device for the treatment of movement, gait, and balance disorders in patients with traumatic brain injury, and other chronic neurological diseases. Helius Medical Technologies, Inc. has a cooperative research and development agreement with the U.S. Army Medical Research and Materiel Command for the development of the PoNS treatment for chronic balance deficits related to mild-to moderate traumatic brain injury. The company is headquartered in Newtown, Pennsylvania.
Cap:    |  Volume (24h):